Actively Recruiting

Phase 4
Age: 18Years - 99Years
All Genders
NCT06268704

Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection

Led by University of New Mexico · Updated on 2025-11-06

230

Participants Needed

1

Research Sites

161 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will compare two different corticosteroids (dexamethasone and methylprednisolone) for use in sacroiliac joint injections to treat SI joint pain.

CONDITIONS

Official Title

Particulate vs. Non-Particulate Steroid for Sacroiliac Joint Injection

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged over 18, able to understand and give consent in English, able to complete outcome assessments, and able to attend all follow-up visits
  • Unilateral low back or buttocks pain lasting at least 2 weeks
  • Average pain score of at least 5 out of 10 over the past 7 days at baseline
  • Clinical diagnosis of sacroiliac joint pain by a board-certified physiatrist with history of low back/buttocks pain and at least 2 positive physical exam signs (such as positive Fortin finger sign, pain on palpation of posterior superior iliac spine, positive FABER's test, positive Gaenslan's test, sacral distraction, thigh thrust, lateral compression, or sacral thrust)
  • Consent to sacroiliac joint corticosteroid injection after shared decision-making with physician
  • At least 80% relief of index pain within 5-15 minutes after injection
Not Eligible

You will not qualify if you...

  • Clinical suspicion of another cause greater than sacroiliac joint pain
  • Receiving payment for pain treatment (e.g., disability, worker's compensation)
  • Involved in active litigation related to pain
  • Unable to read English or complete assessments
  • Unable to attend follow-up visits
  • Incarcerated
  • History of prior sacroiliac joint fusion
  • Progressive lower extremity neurological deficit from radiculopathy or neuromuscular disease
  • Sacroiliac joint steroid injection within past 12 months
  • Two positive lumbar medial branch blocks within past 12 months
  • Radiofrequency ablation of lumbar spine within past 12 months
  • Lumbar facet steroid injections within past 12 months
  • Epidural steroid injection within past 3 months anywhere in the spine
  • Possible pregnancy or reason preventing fluoroscopy use
  • Allergy to steroids, contrast media, or local anesthetics
  • Body mass index over 40
  • Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus)
  • Active infection or recent antibiotic treatment within past 7 days
  • Medical conditions causing significant disability (e.g., stroke, decompensated COPD, heart failure)
  • Chronic widespread pain or somatoform disorder (e.g., fibromyalgia)
  • Addictive behavior, severe depression, or psychotic features

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of New Mexico Hospital

Albuquerque, New Mexico, United States, 87131

Actively Recruiting

Loading map...

Research Team

M

Mark W Shilling, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here